Article Text
Abstract
In Vayena’s article, ‘direct-to-consumer (DTC) genomics on the scales of autonomy’, she claims that there may be a strong autonomy-based argument for permitting DTC genomic services. In this response, I point out how the diminishment of one’s genetic privacy can cause a relevant autonomy-related harm which must be balanced against the autonomy-related gains DTC services provide. By drawing on conceptual connections between privacy and the Razian conception of autonomy, I show that DTC genetic testing may decrease the range of valuable options individuals possess, which impacts the extent to which would-be consumers can exercise their autonomy.
- genetic counseling
- genetic privacy
- personal autonomy
Statistics from Altmetric.com
Footnotes
Contributors All work was done solely by KvO.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- From proband to provider: is there an obligation to inform genetic relatives of actionable risks discovered through direct-to-consumer genetic testing?
- Direct-to-consumer genomics on the scales of autonomy
- Knowing me, knowing you
- Direct-to-consumer genetic testing
- Direct to consumer genetic testing and the libertarian right to test
- Direct to consumer genetic testing
- Commercial DNA tests and police investigations: a broad bioethical perspective
- Ethics of genetic testing and research in sport: a position statement from the Australian Institute of Sport
- Margaret McCartney: Direct to consumer genetic testing—is all knowledge power?
- Disclosure ‘downunder’: misadventures in Australian genetic privacy law